Dolce&Gabbana’s “light therapy” collection celebrates life | Nation & World Business

MILAN (AP) — Dolce & Gabbana are coaxing men off their sofas and back into the world with a resplendent collection inspired by the extravagant lighting installations of southern Italian street festivals.

Designers Domenico Dolce and Stefano Gabbana called their collection “light therapy” for a world that has been mostly denied large gatherings for the last 15 months. Their live runway show Saturday with a socially distanced audience of invited guests was the first inside their showroom since the pandemic forced Milan Fashion Week to go mostly digital in recent seasons. They are just one of several brands with live shows this season.

“Fashion is emotion,’’ Gabbana said backstage before the show. “We experimented last season with a digital show. It is not the same. It was without adrenalin.”

The designers bedecked the showroom with “luminaria” lighting installations reminiscent of southern Italy and sent the models down the runway in

Read More Read More

New Zealand declines to call China’s Uyghur treatment genocide – World


Wellington, New Zealand   ●  
Wed, May 5, 2021


New Zealand shied away from labelling China’s treatment of its Uyghur Muslim minority genocide on Wednesday, once again leaving Wellington out of step with its more forthright Western allies.

Parliament unanimously passed a motion expressing “grave concern” at human rights abuses in Xinjiang province, but only after Prime Minister Jacinda Ardern’s ruling Labour Party insisted any reference to genocide was scrubbed out.

Lawmaker Brooke van Velden said that, while allies such as the United States, Britain and Canada had called what was taking place genocide, it was “intolerable” that New Zealand refused to use the term to avoid upsetting its largest trading partner.

“The world is looking to us now to see what standard we are going to set — can the CCP (Chinese Communist Party) play us off as the weakest link

Read More Read More

The Latest: Connecticut data show COVID-19 vaccine effective | World News

HARTFORD, Conn. — Of the more than 1.4 million Connecticut residents who are now fully vaccinated, 242 later became infected with COVID-19, according to data released Friday from the state Department of Public Health.

Among the 242 so-called “vaccine breakthrough cases,” 109 people had no symptoms of the disease. DPH reported three deaths among vaccinated individuals who were confirmed to have had underlying medical conditions. They were between the ages of 55-64, 65-74, and 75 years and older.

Nationally, there have been 132 vaccine breakthrough deaths, DPH said.

“The main takeaway is that COVID-19 vaccines are highly effective and cases of infection after a person is fully vaccinated are very rare,” Dr. Deidre Gifford, the state’s acting public health commissioner, said in a statement. Cases of COVID-19 in fully vaccinated individuals in Connecticut is less than 0.1%, according to the DPH data.



— Pressure rises on

Read More Read More

Slipping COVID-19 treatment demand hits Eli Lilly forecast | Nation & World Business

INDIANAPOLIS (AP) — Eli Lilly fell well short of Wall Street’s first-quarter expectations, and the drugmaker chopped the top end of its earnings forecast due to lower demand for COVID-19 treatments.

Shares of the Indianapolis company started sliding early Tuesday morning.

Lilly said it now expects 2021 adjusted earnings to range from $7.80 to $8 per share after predicting in late January a range of $7.75 to $8.40.

Analysts forecast, on average, earnings of $8.24 per share, according to FactSet.

Lilly pulled in $810 million in the quarter from sales of COVID-19 treatments and expects to bring in as much as $1.5 billion from the drugs this year. But the company also said it changed its adjusted earnings outlook mainly due to lower expected demand for the treatments and higher research and development costs.

COVID-19 vaccines are being widely delivered across the United States, and the changing virus has limited

Read More Read More

Britain’s Prince Philip returns home after treatment | World News

LONDON (AP) — Britain’s Prince Philip returned to Windsor Castle on Tuesday, following a month in the hospital during which he was treated for an infection and underwent a heart procedure.

Philip, 99, the husband of Queen Elizabeth II, was admitted to the private King Edward VII’s Hospital in London on Feb. 16, where he was treated for an infection.

He was later transferred to a specialized cardiac care unit at St. Bartholomew’s Hospital, before returning to King Edward VII’s.

Photographers standing outside the door of the private hospital captured his departure in the back of a black car. Buckingham Palace later issued a statement confirming Philip’s release.

“His Royal Highness wishes to thank all the medical staff who looked after him at both King Edward VII’s Hospital and St Bartholomew’s Hospital, and everyone who has sent their good wishes,” the palace said in a statement.

Philip’s illness is not

Read More Read More

World Wide Wounds (including woundcare, wound care, wounds, and dressings).

World Wide Wounds – The Electronic Journal of Wound Management Practice<br /> (including woundcare, wound care, wounds, and dressings).<br />

The premier online resource for dressing materials
practical wound management information

What’s new

  • Managing chronic/stalled arterial, venous and pressure ulcers with collagen and oxidised regenerated cellulose dressings The main aim of this article was to provide clinicians with enough high level evidence to assist in decision making when choosing to utilise a collagen ORC dressing in venous, arterial and pressure ulcers.

    E Galea
  • Medicinal use of terrestrial molluscs (slugs and snails) with particular reference to their role in the treatment of wounds and other skin lesions. This paper provides
Read More Read More

Pfizer-BioNTech vaccine sharply reduces symptomatic Covid-19 in the real world, Israeli researchers say

The findings, while preliminary, suggest that the vaccine remains remarkably effective in a mass vaccination campaign — outside the carefully controlled conditions of a clinical trial.

The Clalit Research Institute, part of a large Israeli health system, analyzed data on 1.2 million people, about half of whom had received the Pfizer-BioNTech vaccine. Researchers compared patients who received the vaccine with similar individuals who hadn’t.

The rate of symptomatic Covid-19 — meaning people who were infected with the coronavirus and felt sick — decreased by 94% among people who received two doses of the vaccine, according to a press release from Clalit. The rate of serious illness decreased by 92%.

Full details of the study weren’t immediately available, and the research hasn’t yet been peer-reviewed. Still, the findings are consistent with data from Pfizer’s own vaccine trial, which found that the vaccine conferred 95% protection against symptomatic Covid-19.

“The affirmation is

Read More Read More